—

Curaleaf Holdings Inc. (CURA.TO) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Curaleaf Holdings Inc. ranks 11 of 11 in its cohort on the Closelooknet composite (31/100) — the cohort is led by BB Biotech AG at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
CURA.TO Curaleaf Holdings Inc. 31 63 24 25 — —
ROVI.MC Laboratorios Farmaceuticos ROVI 61 25 78 52 warn 31.8%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 55 91 58 42 ok 4.2%
ALM.MC Almirall S.A. 53 18 46 68 warn 26.2%
FAGR.BR Fagron NV 53 47 57 60 info 8.9%
APTX.TO Apotex Health Corp 46 34 59 50 — —
RDY Dr. Reddy’s Laboratories Ltd ADR 46 29 44 63 info 19.5%
BION.SW BB Biotech AG 73 59 96 81 info 12.9%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ANN.AU Ansell Ltd 64 93 49 53 ok 0.9%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are Curaleaf Holdings Inc.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Apotex Health Corp (APTX.TO), Dr. Reddy’s Laboratories Ltd ADR (RDY), BB Biotech AG (BION.SW), DexCom Inc (DXCM) and others.

How does CURA.TO score against its peers?

Curaleaf Holdings Inc.'s composite reads 31/100, ranking 11 of 11 in its cohort as of 2026-10-06; the cohort's highest composite is BB Biotech AG at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.